Jane Street’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $665K | Buy |
34,700
+13,200
| +61% | +$287K | ﹤0.01% | 7375 |
|
|
2025
Q4 | $473K | Buy |
+21,500
| New | +$388K | ﹤0.01% | 7822 |
|
|
2025
Q3 | – | Sell |
-26,500
| Closed | -$494K | – | 11783 |
|
|
2025
Q2 | $494K | Sell |
26,500
-5,200
| -16% | -$103K | ﹤0.01% | 6948 |
|
|
2025
Q1 | $607K | Sell |
31,700
-72,600
| -70% | -$2.12M | ﹤0.01% | 6502 |
|
|
2024
Q4 | $3.76M | Sell |
104,300
-34,500
| -25% | -$1.17M | ﹤0.01% | 3076 |
|
|
2024
Q3 | $5.89M | Sell |
138,800
-18,700
| -12% | -$793K | ﹤0.01% | 2607 |
|
|
2024
Q2 | $6.35M | Buy |
157,500
+86,400
| +122% | +$3.6M | ﹤0.01% | 2627 |
|
|
2024
Q1 | $2.52M | Buy |
71,100
+27,700
| +64% | +$742K | ﹤0.01% | 3724 |
|
|
2023
Q4 | $1.28M | Buy |
43,400
+33,200
| +325% | +$689K | ﹤0.01% | 5122 |
|
|
2023
Q3 | $212K | Buy |
10,200
+1,700
| +20% | +$46.7K | ﹤0.01% | 7546 |
|
|
2023
Q2 | $209K | Sell |
8,500
-91,100
| -91% | -$2.93M | ﹤0.01% | 7636 |
|
|
2023
Q1 | $4.04M | Buy |
99,600
+74,400
| +295% | +$3.08M | ﹤0.01% | 2737 |
|
|
2022
Q4 | $1.13M | Sell |
25,200
-13,200
| -34% | -$598K | ﹤0.01% | 4784 |
|
|
2022
Q3 | $1.84M | Sell |
38,400
-42,300
| -52% | -$2.32M | ﹤0.01% | 4324 |
|
|
2022
Q2 | $4.78M | Buy |
80,700
+27,700
| +52% | +$2.27M | ﹤0.01% | 2721 |
|
|
2022
Q1 | $6.16M | Sell |
53,000
-34,500
| -39% | -$4.03M | ﹤0.01% | 2689 |
|
|
2021
Q4 | $13.2M | Buy |
87,500
+46,300
| +112% | +$6.25M | ﹤0.01% | 1575 |
|
|
2021
Q3 | $4.92M | Sell |
41,200
-49,200
| -54% | -$5.42M | ﹤0.01% | 2761 |
|
|
2021
Q2 | $8.8M | Sell |
90,400
-27,500
| -23% | -$2.45M | ﹤0.01% | 1862 |
|
|
2021
Q1 | $10.4M | Sell |
117,900
-113,500
| -49% | -$10.5M | 0.01% | 1513 |
|
|
2020
Q4 | $22.1M | Sell |
231,400
-54,500
| -19% | -$5.62M | 0.01% | 809 |
|
|
2020
Q3 | $32.5M | Buy |
285,900
+124,300
| +77% | +$13.1M | 0.02% | 549 |
|
|
2020
Q2 | $16M | Buy |
161,600
+151,400
| +1,484% | +$12.1M | 0.01% | 868 |
|
|
2020
Q1 | $656K | Sell |
10,200
-42,400
| -81% | -$2.97M | ﹤0.01% | 3328 |
|
|
2019
Q4 | $3.13M | Buy |
52,600
+17,900
| +52% | +$1.1M | ﹤0.01% | 1474 |
|
|
2019
Q3 | $2.05M | Sell |
34,700
-23,600
| -40% | -$1.51M | ﹤0.01% | 1770 |
|
|
2019
Q2 | $3.76M | Buy |
58,300
+20,900
| +56% | +$1.35M | 0.01% | 1286 |
|
|
2019
Q1 | $2.38M | Buy |
37,400
+32,000
| +593% | +$1.68M | ﹤0.01% | 1848 |
|
|
2018
Q4 | $205K | Buy |
+5,400
| New | +$191K | ﹤0.01% | 4461 |
|
Other funds holding TNDM
SC
VPM
ACH
VCM
GKIM
DCM
Jane Street's TNDM Position: Q1 2026 in Review
Jane Street sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 209,975 shares — an estimated $4.56M sold.
Jane Street first reported a position in TNDM in Q1 2014 and held it in 28 quarters. The position peaked at $16.7M in Q2 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.
- Jane Street reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 209,975 Tandem Diabetes Care shares in Q1 2026, an estimated $4.56M.
- Jane Street first reported a position in Tandem Diabetes Care in Q1 2014 and held it in 28 quarters.
- Jane Street's Tandem Diabetes Care position peaked at $16.7M in Q2 2020.
- 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.